Hilary D'Anna
Senior Manager, Patient Advocacy and Engagement at Audentes Therapeutics - San Francisco, California, US
Hilary D'Anna's Colleagues at Audentes Therapeutics
Todd Rozewicz
Senior Director, Gene Therapy COE Financial Planning and Analysi
Hilary D'Anna's Contact Details
(415) 818-1005
Philadelphia, Pennsylvania, United States
Audentes Therapeutics
Hilary D'Anna's Company Details
Audentes Therapeutics is a leading AAV-based genetic medicines company focused on developing and commercializing innovative products for serious rare neuromuscular diseases. We are leveraging our AAV gene therapy technology platform and proprietary manufacturing expertise to develop programs across three modalities: gene replacement, vectorized exon skipping, and vectorized RNA knockdown. Our product candidates are showing promising therapeutic profiles in clinical and preclinical studies across a range of neuromuscular diseases. Audentes is a focused, experienced and passionate team driven by the goal of improving the lives of patients. If you are interested in learning more about our company, please do not hesitate to contact us.